Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-030535

Chief Operating Officer gave up 535 shares (to pay taxes)

  • Chief Operating Officer acquired 1,791 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-30 Exercise or conversion : show line 1 in the form +1,791 40,404 D
2024-09-30 Shares withheld for taxes : show line 2 in the form −535 $6.74 $3,606 39,869 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,791 12,864 D
Loading xslF345X05/rdgdoc.xml…